Related News
Apr 24, 2026
DeepSeek's Open-Source A.I. Surge: Game Changer in Global Competition
DeepSeek's release of its open-source V4 model propels its position in the A.I. race, challenging American giants with cost-efficiency and openness. For global builders, this marks a new era of accessible, powerful tools for software development.
Apr 20, 2026
Toronto Startup Biossil Uses AI to Revive Failed Drugs with Peter Thiel's Backing
Peter Thiel and OpenAI back Toronto's Biossil, a startup using AI to give new purposes to failed drugs. With CAD $12M in seed funding, Biossil's "DrugRevive" platform leverages AI to cut drug repurposing time by 70-80%, bringing shelved therapies to trial faster. Promising early results include an oncology drug repurposed for a neurological disorder, now in Phase 2 trials.
Apr 14, 2026
Tesla's Bold AI Gamble: Could Robotics Be the Key to its Future Supremacy?
Facing challenges in 2026, Tesla's share prices have declined amid missed delivery targets and increased inventory. However, the company is eyeing a transformation by venturing into robotics and AI. With plans for autonomous robotaxis and the humanoid Optimus, Tesla could redefine itself beyond just an EV maker. The shift sparks debates on risks versus potential high rewards.